An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-06-28
DOI
10.3389/fphar.2017.00422
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neuronal and molecular effects of cannabidiol on the mesolimbic dopamine system: Implications for novel schizophrenia treatments
- (2017) Justine Renard et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia
- (2017) Marco Aurélio Mori et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease
- (2017) Georgia Watt et al. Frontiers in Pharmacology
- Synthesis of (−)-Cannabimovone and Structural Reassignment of Anhydrocannabimovone through Gold(I)-Catalyzed Cycloisomerization
- (2016) Javier Carreras et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Metabolic effects of orally administered small-molecule agonists of GPR55 and GPR119 in multiple low-dose streptozotocin-induced diabetic and incretin-receptor-knockout mice
- (2016) Aine M. McKillop et al. DIABETOLOGIA
- THC:CBD in Daily Practice: Available Data from UK, Germany and Spain
- (2016) Óscar Fernández EUROPEAN NEUROLOGY
- Abnormal cannabidiol attenuates experimental colitis in mice, promotes wound healing and inhibits neutrophil recruitment
- (2016) Regina M. Krohn et al. Journal of Inflammation-London
- Evolution of the Cannabinoid and Terpene Content during the Growth of Cannabis sativa Plants from Different Chemotypes
- (2016) Oier Aizpurua-Olaizola et al. JOURNAL OF NATURAL PRODUCTS
- Atropisomerism about Aryl–C(sp3) Bonds: Conformational Behavior of Substituted Phenylcyclohexanes in Solution
- (2016) Manon Flos et al. JOURNAL OF ORGANIC CHEMISTRY
- Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
- (2016) Orrin Devinsky et al. LANCET NEUROLOGY
- Phytocannabinoids: a unified critical inventory
- (2016) Lumír Ondřej Hanuš et al. NATURAL PRODUCT REPORTS
- Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects
- (2016) Aviva Breuer et al. PLoS One
- Discovery of KLS-13019, a Cannabidiol-Derived Neuroprotective Agent, with Improved Potency, Safety, and Permeability
- (2016) William A. Kinney et al. ACS Medicinal Chemistry Letters
- Unknown
- (2016) BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol (CBD) and its analogs: a review of their effects on inflammation
- (2015) Sumner Burstein BIOORGANIC & MEDICINAL CHEMISTRY
- Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
- (2015) R B Laprairie et al. BRITISH JOURNAL OF PHARMACOLOGY
- HU-446 and HU-465, Derivatives of the Non-psychoactive Cannabinoid Cannabidiol, Decrease the Activation of Encephalitogenic T Cells
- (2015) Ewa Kozela et al. Chemical Biology & Drug Design
- Progress report on new antiepileptic drugs: A summary of the Twelfth Eilat Conference (EILAT XII)
- (2015) Meir Bialer et al. EPILEPSY RESEARCH
- Fatty Acid-binding Proteins (FABPs) Are Intracellular Carriers for Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD)
- (2015) Matthew W. Elmes et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cannabidiol-2’,6’-dimethyl ether stimulates body weight gain in apolipoprotein E-deficient BALB/c. KOR/Stm Slc-Apoeshl mice
- (2015) Shuso Takeda et al. JOURNAL OF TOXICOLOGICAL SCIENCES
- Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma
- (2015) Francieli Vuolo et al. MEDIATORS OF INFLAMMATION
- Molecular Targets of Cannabidiol in Neurological Disorders
- (2015) Clementino Ibeas Bih et al. Neurotherapeutics
- CB2 cannabinoid receptor agonist enantiomers HU-433 and HU-308: An inverse relationship between binding affinity and biological potency
- (2015) Reem Smoum et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Activation of GPR18 by cannabinoid compounds: a tale of biased agonism
- (2014) Linda Console-Bram et al. BRITISH JOURNAL OF PHARMACOLOGY
- HU-331 Is a Catalytic Inhibitor of Topoisomerase IIα
- (2014) Kellie M. Regal et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Antidepressant-Like and Anxiolytic-Like Effects of Cannabidiol: A Chemical Compound of Cannabis sativa
- (2014) Alexandre Schier et al. CNS & Neurological Disorders-Drug Targets
- Cannabidiol improves lung function and inflammation in mice submitted to LPS-induced acute lung injury
- (2014) A. Ribeiro et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- The Effect of Cannabidiol on Ischemia/Reperfusion-Induced Ventricular Arrhythmias
- (2014) Ersöz Gonca et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Atropisomerism about Aryl–Csp3 Bonds: The Electronic and Steric Influence of ortho-Substituents on Conformational Exchange in Cannabidiol and Linderatin Derivatives
- (2014) Hatice Berber et al. JOURNAL OF ORGANIC CHEMISTRY
- Early phytocannabinoid chemistry to endocannabinoids and beyond
- (2014) Raphael Mechoulam et al. NATURE REVIEWS NEUROSCIENCE
- Differences in receptor binding affinity of several phytocannabinoids do not explain their effects on neural cell cultures
- (2014) Sarah Rosenthaler et al. NEUROTOXICOLOGY AND TERATOLOGY
- Δ9-THC and N-arachidonoyl glycine regulate BV-2 microglial morphology and cytokine release plasticity: implications for signaling at GPR18
- (2014) Douglas McHugh et al. Frontiers in Pharmacology
- Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease
- (2013) Francesca Borrelli et al. BIOCHEMICAL PHARMACOLOGY
- Structural Requirements for Potent Direct Inhibition of Human Cytochrome P450 1A1 by Cannabidiol: Role of Pentylresorcinol Moiety
- (2013) Satoshi Yamaori et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1receptor-independent mechanism
- (2013) T D M Hill et al. BRITISH JOURNAL OF PHARMACOLOGY
- Epigenetic control of skin differentiation genes by phytocannabinoids
- (2013) Mariangela Pucci et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cyclohexa-2,5-diene-1,4-dione-based antiproliferative agents: design, synthesis, and cytotoxic evaluation
- (2013) Carmen Petronzi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists
- (2013) Sangdon Han et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression in SHSY5YAPP+Cells Through PPARγ Involvement
- (2013) Caterina Scuderi et al. PHYTOTHERAPY RESEARCH
- Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?
- (2012) Javier Fernández-Ruiz et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Cannabidiol as potential anticancer drug
- (2012) Paola Massi et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Cannabidivarin is anticonvulsant in mouse and rat
- (2012) AJ Hill et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
- (2012) Wei Xiong et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Anti-Inflammatory Role of Cannabidiol and O-1602 in Cerulein-Induced Acute Pancreatitis in Mice
- (2012) Kun Li et al. PANCREAS
- Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration
- (2012) Shuso Takeda et al. TOXICOLOGY LETTERS
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- (2012) F M Leweke et al. Translational Psychiatry
- Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation
- (2011) L. De Petrocellis et al. Acta Physiologica
- Evaluation of the Cyclooxygenase Inhibiting Effects of Six Major Cannabinoids Isolated from Cannabis sativa
- (2011) Lucia Renee Ruhaak et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT1A somatodendritic autoreceptors in the dorsal raphe nucleus
- (2011) EM Rock et al. BRITISH JOURNAL OF PHARMACOLOGY
- Δ9-Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells
- (2011) Douglas McHugh et al. BRITISH JOURNAL OF PHARMACOLOGY
- Curcumin nanoformulations: a future nanomedicine for cancer
- (2011) Murali M. Yallapu et al. DRUG DISCOVERY TODAY
- Modulation of l-α-Lysophosphatidylinositol/GPR55 Mitogen-activated Protein Kinase (MAPK) Signaling by Cannabinoids
- (2011) Sharon Anavi-Goffer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans
- (2011) Silvana Y Romero-Zerbo et al. JOURNAL OF ENDOCRINOLOGY
- Ferruginenes A−C fromRhododendron ferrugineumand Their Cytotoxic Evaluation
- (2011) Prapairat Seephonkai et al. JOURNAL OF NATURAL PRODUCTS
- Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study
- (2011) Lourdes Ruiz-Valdepeñas et al. Journal of Neuroinflammation
- Cannabidiol Reduces Brain Damage and Improves Functional Recovery After Acute Hypoxia-Ischemia in Newborn Pigs
- (2011) Hector Lafuente et al. PEDIATRIC RESEARCH
- Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement
- (2011) Giuseppe Esposito et al. PLoS One
- Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis
- (2010) Sean D. McAllister et al. BREAST CANCER RESEARCH AND TREATMENT
- Phytocannabinoids beyond the Cannabis plant - do they exist?
- (2010) J������rg Gertsch et al. BRITISH JOURNAL OF PHARMACOLOGY
- A role for L-α-lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells
- (2010) Lesley A Ford et al. BRITISH JOURNAL OF PHARMACOLOGY
- Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action
- (2010) Sabatino Maione et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabimovone, a Cannabinoid with a Rearranged Terpenoid Skeleton from Hemp
- (2010) Orazio Taglialatela-Scafati et al. EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
- The Nonpsychoactive Cannabinoid Cannabidiol Inhibits 5-Hydroxytryptamine3A Receptor-Mediated Currents in Xenopus laevis Oocytes
- (2010) K. H. Yang et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The Challenge of Atropisomerism in Drug Discovery
- (2009) Jonathan Clayden et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Evidence that the plant cannabinoid cannabigerol is a highly potent α2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist
- (2009) MG Cascio et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol-2',6'-Dimethyl Ether, a Cannabidiol Derivative, Is a Highly Potent and Selective 15-Lipoxygenase Inhibitor
- (2009) S. Takeda et al. DRUG METABOLISM AND DISPOSITION
- Time-dependent vascular actions of cannabidiol in the rat aorta
- (2009) Saoirse E. O'Sullivan et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Lipid G Protein-coupled Receptor Ligand Identification Using β-Arrestin PathHunter™ Assay
- (2009) Hong Yin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
- (2009) Sagnik Bhattacharyya et al. NEUROPSYCHOPHARMACOLOGY
- The Nonpsychotropic Cannabinoid Cannabidiol Modulates and Directly Activates Alpha-1 and Alpha-1-Beta Glycine Receptor Function
- (2009) Jörg Ahrens et al. PHARMACOLOGY
- The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo
- (2009) L. S. Whyte et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cannabidiolic Acid as a Selective Cyclooxygenase-2 Inhibitory Component in Cannabis
- (2008) S. Takeda et al. DRUG METABOLISM AND DISPOSITION
- Antibacterial Cannabinoids fromCannabis sativa: A Structure−Activity Study
- (2008) Giovanni Appendino et al. JOURNAL OF NATURAL PRODUCTS
- GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current
- (2008) J. E. Lauckner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects
- (2007) D G Johns et al. BRITISH JOURNAL OF PHARMACOLOGY
- The orphan receptor GPR55 is a novel cannabinoid receptor
- (2007) E Ryberg et al. BRITISH JOURNAL OF PHARMACOLOGY
- Meta-analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences
- (2007) J M McPartland et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
- (2007) A Thomas et al. BRITISH JOURNAL OF PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now